Publications
- Immunoglobulin replacement therapy in the Czech Republic: end-of-year 2020 data from the National registry of primary immunodeficiencies2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA2022 | Second Faculty of Medicine, First Faculty of Medicine
- Principles and new perspectives in the vaccination against SARS-CoV-2 virus2020 | Second Faculty of Medicine
- CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hyrimoz - new biosimilars in treatment of rheumatoid arthritis2019 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
Loading network view...